Study directly compares Zepbound and Wegovy for weight-loss results
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others?The question was explored in a new study published this month in The New England Journal of Medicine.Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a 72-week clinical trial.WEIGHT-LOSS MEDICATIONS MAY ALSO BENEFIT COMMON MEDICAL PROBLEM, STUDY FINDSThe randomized, controlled trial — called […]